Selected publications:
Barti B, Dudok B, Kenesei K, Zöldi M, Miczán V, Balla GY, Zala D, Tasso M, Sagheddu Cl, Kisfali M, Tóth B, Ledri M, Vizi ES, Melis M, Barna L, Lenkei Z, Soltész I, Katona I (2024) Presynaptic nanoscale components of retrograde synaptic signaling. Science Advances 10 : 22 Paper: eado0077
Prokop S, Ábrányi-Balogh P, Barti B. Vámosi M, Zöldi M, Barna L, Urbán GM, Tóth AD, Dudok B, Egyed A, Deng H, Leggio GM, Hunyady L, van der Stelt M, Keserű GM and Katona I. (2021) PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells. Nature Communications 12:6505.
László Z, Lele Z, Zöldi M, Miczán V, Mógor F, Simon GM, Mackie K, Kacskovics I, Cravatt BF and Katona I (2020) ABHD4-mediated developmental anoikis safeguards the embryonic brain. Nature Communications, 11:4363.
*Frau R, *Miczan V, Traccis F, Aroni S, Pongor C, Saba P, Serra V, Sagheddu C, Fanni S, Congiu M, Devoto P, Cheer J, *Katona I and *Melis M (2019) Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nature Neuroscience, 22:1975-1985. *equal contribution
Younts TJ, Monday HR, Dudok B, Klein ME, Jordan BA, Katona I and Castillo PE (2016) Presynaptic protein synthesis is required for long-term plasticity of GABA release. Neuron, 92:479-492.
Barna L, Dudok B, Miczán V, Horváth A, László ZI and Katona I (2016) Correlated confocal and super[1]resolution imaging by VividSTORM. Nature Protocols, 11:163-183.
Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, Watanabe M, Sagheddu C, Melis M, Pistis M, Soltesz I and Katona I (2015) Cell-specific STORM superresolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience, 18:75-86.
Lee SH, Ledri M, Tóth B, Marchionni I, Henstridge CM, Dudok B, Kenesei K, Barna L, Szabó SI, Renkecz T, Oberoi M, Watanabe M, Limoli CL, Horvai G, Soltesz I and Katona I (2015) Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. The Journal of Neuroscience, 35:10039-57.
Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I*, Piomelli D* and Manzoni OJ* (2012) Uncoupling of the endocannabinoid signaling complex in a mouse model of fragile X syndrome. Nature Communications, 3:1080. *equal contribution
Katona I and Freund TF (2012) Multiple functions of endocannabinoid signaling in the brain. Annual Review of Neuroscience, 35:529-558.
Katona I and Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nature Medicine, 14:923-930.
Ludányi A, Erőss L, Czirják S, Vajda P, Halász P, Watanabe M, Palkovits M, Maglóczky Z, Freund TF and Katona I (2008) Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. The Journal of Neuroscience, 28:2976-2990.
Katona I, Urbán GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K and Freund TF (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. The Journal of Neuroscience, 24:5268-5237.
Katona I, Sperlágh B, Sik A, Kőfalvi A, Vizi ES, Mackie K and Freund TF (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. The Journal of Neuroscience, 19: 4544-4558.